NASDAQ:CBPO

China Biologic Reports Financial Results for the Second Quarter of 2019

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to$41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms-- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to$79.3 Million; Non-GAA...

2019-08-06 04:30 8239

China Biologic Products to Report Second Quarter 2019 Financial Results

BEIJING, July 26, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2019 financial resu...

2019-07-27 04:30 10301

China Biologic Reports Financial Results for the First Quarter of 2019

--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING, May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"...

2019-05-11 04:30 9523

China Biologic Products to Report First Quarter 2019 Financial Results

BEIJING, April 30, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its first quarter 2019 financial results ...

2019-04-30 20:00 7712

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

-- 4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; Net Income Up $59.4 Million YoY to $34.8 Million; Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms -- -- FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; Net Income Up 88.7% YoY to $128.1 Million; ...

2019-03-07 06:00 9227

China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results

BEIJING, Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its fourth quarter and fiscal year 2018 fi...

2019-02-25 21:00 7121

China Biologic Reiterates Full Year 2018 Financial Forecast

BEIJING, Jan. 7, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO)("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today reiterated its previously revised full year 2018 forecast. Full year 2018 non-GAAP adju...

2019-01-07 21:00 10569

China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman

BEIJING, Dec. 14, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Grand Court of theCayman Islands (the "Court") dismissed the lawsui...

2018-12-14 21:00 2543

China Biologic Reports Financial Results for the Third Quarter of 2018

3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms; Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms; Net Income Up 4.1% YoY to $32.9 Million Board of Directors Approves $100 Million Share Repurchase Program BEIJING, Nov. 1, 2018 /PRNewswire/ -- China Biologic Products...

2018-11-02 04:30 1254

China Biologic Products to Report Third Quarter 2018 Financial Results

BEIJING, Oct. 24, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its third quarter 2018 financial results o...

2018-10-24 20:00 1080

China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman

BEIJING, Aug. 28, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today issued the following statement in response to a lawsuit filed against the Company in t...

2018-08-29 05:00 1946

China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement

BEIJING, Aug. 24, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company's board of directors (the "Board") has received a letter da...

2018-08-24 20:00 2231

China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal

BEIJING, Aug. 21, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that its board of directors (the "Board") has received an unsolicited, preli...

2018-08-21 20:00 1489

China Biologic Names Bing Li as New CEO

BEIJING, Aug. 13, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company's Board of Directors (the "Board") has appointed Dr. Bing L...

2018-08-13 20:00 1226

China Biologic Reports Financial Results for the Second Quarter of 2018

-- 2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.8% YoY in RMB terms, or  Total Sales Up 34.8% YoY to $120.4 Million and Net Income Down 7.7% YoY to $28.6 Million in USD terms -- -- 1H18 Total Sales Up 19.5% YoY and Non-GAAP Adjusted Net Income Down 0.4% YoY in RMB terms,...

2018-08-04 04:30 1912

China Biologic Products to Report Second Quarter 2018 Financial Results

BEIJING, July 27, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its second quarter 2018 financial results ...

2018-07-27 20:00 3142

China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders

BEIJING, July 2, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced the results of the Company's 2018 Annual General Meeting of Shareholders (the "Annual ...

2018-07-02 20:30 1267

China Biologic Announces Receipt of Non-Binding Acquisition Proposal

BEIJING, June 19, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that its board of directors (the "Board") has received an unsolicited, preliminary non...

2018-06-19 20:00 1206

China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant

BEIJING, June 11, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that Shandong Taibang Biological Products Co. Ltd., the Company's majority...

2018-06-11 20:00 1206

China Biologic Reports Financial Results for the First Quarter of 2018

--1Q18 Total Sales Up 13.7% YoY and Non-GAAP Adjusted Net Income Up 2.1% YoY in RMB terms, or  Total Sales Up 23.0% YoY to $112.5 Million and Net Income Up 5.3% YoY to $31.6 Million in USD terms-- BEIJING, May 4, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China ...

2018-05-05 04:30 3087
123

Week's Top Stories